Reported about 20 hours ago
Merck has commenced construction on a $3 billion manufacturing facility in Elkton, Virginia, as part of a broader $70 billion effort to enhance its manufacturing and R&D capabilities in the U.S. This initiative follows a push for increased domestic medicine production. The new site is expected to create 500 jobs, significantly exceeding earlier projections, and contributes to the broader trend of pharmaceutical companies boosting U.S. investments amid ongoing supply chain concerns.
Source: YAHOO